Prestige Consumer Healthcare Narrows FY26 Revenue Outlook to $1.1B Amid Clear Eyes Supply Recovery

jueves, 5 de febrero de 2026, 5:30 pm ET1 min de lectura
PBH--

Prestige Consumer Healthcare has narrowed its fiscal 2026 revenue outlook to $1.1 billion. The company reported Q3 2026 sales of $283 million, slightly better than forecast. CEO Ron Lombardi attributed the results to solid order trends in a diverse customer base. The company is also advancing its Clear Eyes supply recovery.

Prestige Consumer Healthcare Narrows FY26 Revenue Outlook to $1.1B Amid Clear Eyes Supply Recovery

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios